Topic
Innovative application architecture gives users clearer insight into AI responses, improves output reliability, and strengthens data alignment across LINK AI®, ANONYMIZE®, and REGISTRY® CANTON, Mich. – TrialAssure, a leading…
CANTON, Mich. (December 10, 2024) – TrialAssure®, a global leader in AI-enabled, human-driven solutions for the pharmaceutical industry and beyond, today announced a groundbreaking addition to its TrialAssure…
SAN DIEGO – TrialAssure, a leading provider of pharmaceutical technology advancing clinical trial disclosure, data sharing, and transparency, announced today the release of TrialAssure LINK® AI 2.0. This new…
CANTON, Mich. (April 22, 2024) — TrialAssure today announced it has joined NVIDIA Inception, a program that nurtures companies revolutionizing industries with technological advancements. TrialAssure is a leader…
TrialAssure has announced that Certara (Nasdaq: CERT) – the global leader in biosimulation – has licensed TrialAssure’s ANONYMIZE software to anonymize clinical data.
CANTON, Mich. (April 16, 2020) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today the addition of Kelly Vaillant as Director, Global Transparency Strategy…
CANTON, Mich. (April 10, 2020) – TrialAssure® – the technology arm of MMS and leading, global software company focused on advancing clinical trial transparency – has won the…
CANTON, Mich. (April 7, 2020) – TrialAssure® – a leading, global software company focused on developing clinical trial transparency tools – announced today that it will offer academic…
I would like to take a moment and share our commitment to the highest levels of health and improving lives worldwide, amidst the outbreak of COVID-19. The health…
Canton, Mich. (November 7, 2019) – TrialAssure® – a leading, global software company advancing clinical trial transparency tools – announced today the limited release of ANONYMIZE R, a…
